What are the common causes of basophilia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Basophilia

Basophilia is most commonly caused by chronic myeloid leukemia (CML) and other myeloproliferative neoplasms (MPNs), with allergic/inflammatory conditions and parasitic infections representing the primary reactive causes. 1, 2

Neoplastic Causes (Most Important)

Chronic Myeloid Leukemia and Myeloproliferative Neoplasms

  • CML is the most frequent neoplastic cause of basophilia, with basophilia present in the majority of cases and considered a hallmark feature. 1, 3

  • Basophilia ≥20% in blood or bone marrow is a defining criterion for accelerated phase CML according to both WHO and European LeukemiaNet guidelines. 1

  • Primary myelofibrosis (PMF), especially CALR-positive cases, shows strong association with persistent basophilia, which may predict progression to acute myeloid leukemia. 4

  • Essential thrombocythemia and polycythemia vera can present with basophilia as part of the MPN spectrum. 5

  • Hyperbasophilia (absolute basophil count ≥1000/μL) is highly indicative of an underlying myeloid neoplasm and requires immediate hematologic investigation including bone marrow biopsy, cytogenetics, and molecular testing for BCR-ABL1 and other tyrosine kinase fusions. 6

Acute Leukemias

  • Acute basophilic leukemia (ABL) is rare but represents a distinct entity requiring ≥20% basophils among bone marrow blasts. 6

  • Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes (PDGFRA, PDGFRB, FGFR1, ABL1, JAK2) frequently present with concurrent basophilia. 1

Reactive (Secondary) Causes

Allergic and Inflammatory Conditions

  • Allergic disorders including asthma, allergic rhinitis, atopic dermatitis, and food allergies account for approximately 80% of reactive basophilia cases in non-endemic regions. 7, 8, 9

  • Chronic inflammatory conditions and autoimmune diseases can produce mild basophilia. 8

Infectious Causes

  • Parasitic infections, particularly tissue-invasive helminths (Strongyloides, Ascaris, hookworm, Schistosoma), are the second most common cause of reactive basophilia, especially in travelers and migrants from endemic areas. 7, 8, 9

  • Strongyloides stercoralis infection can persist lifelong and cause fatal hyperinfection syndrome in immunocompromised patients, making exclusion mandatory even in asymptomatic basophilia. 7, 9

Medication-Induced

  • Drug reactions, particularly to beta-lactam antibiotics, nitrofurantoin, and non-steroidal anti-inflammatory drugs, can cause basophilia. 8, 9

Other Reactive Causes

  • Chronic infections, including tuberculosis in resource-limited settings, may present with basophilia. 8

  • Solid tumors in advanced stages can rarely cause paraneoplastic basophilia. 8

Critical Diagnostic Approach

When to Suspect Neoplastic Basophilia

  • Absolute basophil count ≥1000/μL mandates bone marrow evaluation with cytogenetics (including FISH for BCR-ABL1) and molecular testing for tyrosine kinase fusions. 6

  • Persistent basophilia >3 months despite treatment of reactive causes requires hematology referral for evaluation of myeloid neoplasm. 4, 2

  • Basophilia accompanied by splenomegaly, thrombocytosis, leukocytosis with myeloid immaturity, or constitutional symptoms strongly suggests MPN. 1

Diagnostic Pitfalls to Avoid

  • Automated hematology analyzers significantly underestimate basophil counts in myeloid neoplasms (mean 2.7% by analyzer vs 7.1% by manual differential); manual differential and flow cytometry are required for accurate quantitation in suspected MPN. 5

  • Do not attribute basophilia solely to known allergic conditions without excluding helminth infections in travelers/migrants or myeloid neoplasms in persistent cases. 9, 2

  • Spurious basophilia from platelet clumping, nucleated red blood cells, or other interfering substances must be excluded by manual review before pursuing extensive workup. 2

Systematic Evaluation Algorithm

  • Step 1: Confirm true basophilia by manual differential to exclude spurious elevation from automated analyzer artifact. 5, 2

  • Step 2: If basophilia confirmed, assess for reactive causes—obtain detailed travel/exposure history, medication review, and evaluate for allergic/atopic conditions. 2

  • Step 3: In travelers/migrants, perform three concentrated stool specimens for ova/parasites, Strongyloides serology, and Schistosomiasis serology based on exposure history. 7, 9

  • Step 4: If absolute basophil count ≥1000/μL or basophilia persists >3 months without identified reactive cause, proceed to bone marrow biopsy with cytogenetics and molecular testing for BCR-ABL1 and other tyrosine kinase fusions. 2, 6

  • Step 5: In confirmed myeloid neoplasm with basophilia, monitor for disease progression—basophilia ≥20% defines accelerated phase in CML, and persistent marked basophilia in PMF predicts AML transformation. 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

How I investigate basophilia in daily practice.

International journal of laboratory hematology, 2020

Research

Cytogenetic studies in basophilic chronic myelocytic leukemia.

Archives of pathology & laboratory medicine, 1979

Research

Automated analysers underestimate atypical basophil count in myeloid neoplasms.

International journal of laboratory hematology, 2022

Guideline

Eosinophilia Evaluation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Eosinophilia Causes and Clinical Manifestations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Eosinophilia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.